Navocaftor
Modify Date: 2024-01-16 11:11:06
Navocaftor structure
|
Common Name | Navocaftor | ||
|---|---|---|---|---|
| CAS Number | 2159103-66-7 | Molecular Weight | 416.33 | |
| Density | 1.6±0.1 g/cm3 | Boiling Point | 634.0±65.0 °C at 760 mmHg | |
| Molecular Formula | C15H11F3N4O5S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 337.2±34.3 °C | |
Use of NavocaftorNavocaftor, as a cystic fibrosis transmembrane regulator (CFTR), is a protein modulator (US 20200377491 Al, example 1)[1]. |
| Name | [5-(3-Amino-5-{[4-(trifluoromethoxy)phenyl]sulfonyl}-2-pyridinyl)-1,3,4-oxadiazol-2-yl]methanol |
|---|---|
| Synonym | More Synonyms |
| Description | Navocaftor, as a cystic fibrosis transmembrane regulator (CFTR), is a protein modulator (US 20200377491 Al, example 1)[1]. |
|---|---|
| Related Catalog | |
| Target |
CFTR[1] |
| In Vitro | Navocaftor, as a cystic fibrosis transmembrane regulator (CFTR), is a protein modulator[1]. |
| References |
[1]. US 20200377491 Al |
| Density | 1.6±0.1 g/cm3 |
|---|---|
| Boiling Point | 634.0±65.0 °C at 760 mmHg |
| Molecular Formula | C15H11F3N4O5S |
| Molecular Weight | 416.33 |
| Flash Point | 337.2±34.3 °C |
| Exact Mass | 416.040222 |
| LogP | 2.50 |
| Vapour Pressure | 0.0±2.0 mmHg at 25°C |
| Index of Refraction | 1.581 |
| [5-(3-Amino-5-{[4-(trifluoromethoxy)phenyl]sulfonyl}-2-pyridinyl)-1,3,4-oxadiazol-2-yl]methanol |
| 1,3,4-Oxadiazole-2-methanol, 5-[3-amino-5-[[4-(trifluoromethoxy)phenyl]sulfonyl]-2-pyridinyl]- |